EquityZen Co-Founder and Chief Strategy Officer Phil Haslett joins Yahoo Finance Live to discuss the state of the U.S. IPO market and startups in the private market.
Doximity's (DOCS) fiscal fourth-quarter results are likely to reflect continued strength in its telehealth platform.
Biotech is one of the fastest growing areas in healthcare, and one of the more exciting sectors in the stock market. Here's why three Fool.com contributors are bullish on 10x Genomics (NASDAQ: TXG), Axsome Therapeutics (NASDAQ: AXSM), and Doximity (NYSE: DOCS). 10x Genomics sells the machines and associated consumables that allow scientists to look in and around a single cell, referred to as spatial biology.